Inhibition of PAI (Plasminogen Activator Inhibitor)-1 Improves Brain Collateral Perfusion and Injury After Acute Ischemic Stroke in Aged Hypertensive Rats

被引:51
|
作者
Chan, Siu-Lung [1 ]
Bishop, Nicole [1 ]
Li, Zhaojin [1 ]
Cipolla, Marilyn J. [1 ,2 ,3 ]
机构
[1] Univ Vermont, Larner Coll Med, Dept Neurol Sci, 149 Beaumont Ave,HSRF 416A, Burlington, VT 05405 USA
[2] Univ Vermont, Larner Coll Med, Dept Obstet Gynecol & Reprod Sci, Burlington, VT USA
[3] Univ Vermont, Dept Pharmacol, Larner Coll Med, Burlington, VT 05405 USA
基金
美国国家卫生研究院;
关键词
aging; erythrocyte aggregation; hypertension; reperfusion; stroke; PLASMINOGEN-ACTIVATOR INHIBITOR-1; AMYLOID BETA-PEPTIDE; HEMORRHAGIC TRANSFORMATION; ENDOTHELIAL-CELLS; BLOOD-FLOW; A-BETA; REACTIVITY; NEURODEGENERATION; EPIDEMIOLOGY; DYSFUNCTION;
D O I
10.1161/STROKEAHA.118.022056
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose Aging and hypertension, comorbidities prevalent in the stroke population, are associated with poor collateral status and worsened stroke outcome. However, underlying mechanisms by which these conditions affect stroke outcome are not clear. We studied the role of PAI (plasminogen activator inhibitor)-1 that is increased in aging and hypertension on brain and vascular expression of inflammatory factors and perfusion that may contribute to worse stroke outcomes. Methods Aged (approximate to 50 weeks) and young (approximate to 18 weeks) spontaneously hypertensive rats (SHR) were subjected to ischemia by middle cerebral artery occlusion (2 hours) and reperfusion (2 hours) with or without treatment with the PAI-1 inhibitor TM5441. Changes in middle cerebral artery and collateral perfusion territories were measured by multisite laser Doppler. Reactivity to TM5441 was studied using isolated and pressurized leptomeningeal anastomotic arterioles. Brain injury was determined by 2,3,5-triphenyltetrazolium staining and quantitative immunohistochemistry of amyloid--42, PAI-1, and hemoglobin. Circulating inflammatory factors were measured by ELISA. Results Changes in cerebral blood flow during middle cerebral artery occlusion were similar between groups, with both having poor collateral perfusion and incomplete reperfusion. However, aged SHR had greater brain injury versus young (412 versus 23 +/- 2%, P<0.05) as well as increased brain deposition of amyloid--42 and circulating oxLDL (oxidized low-density lipoprotein). Erythrocyte aggregation and hemorrhage within the injured brain was observed in 50% of aged but no young SHR, with increased circulating PAI-1 in this subgroup of aged SHR (16 +/- 3 versus 6 +/- 2 ng/mL, P<0.05). PAI-1 inhibition with TM5441 improved brain injury but did not affect hemorrhage. TM5441 increased collateral perfusion by 38 +/- 7% and dilated leptomeningeal anastomotic arterioles by 44 +/- 10%, which was abolished by nitric oxide synthase inhibition. Conclusions Increased injury in aged SHR seemed to be related to poor collateral perfusion, hemorrhagic transformation, increased amyloid--42, and oxidative stress. PAI-1 inhibition reduced infarction in both groups of SHR that possibly due, in part, to increased collateral perfusion.
引用
收藏
页码:1969 / 1976
页数:8
相关论文
共 50 条
  • [1] Bryostatin Improves Survival and Reduces Ischemic Brain Injury in Aged Rats After Acute Ischemic Stroke
    Tan, Zhenjun
    Turner, Ryan C.
    Leon, Rachel L.
    Li, Xinlan
    Hongpaisan, Jarin
    Zheng, Wen
    Logsdon, Aric F.
    Naser, Zachary J.
    Alkon, Daniel L.
    Rosen, Charles L.
    Huber, Jason D.
    STROKE, 2013, 44 (12) : 3490 - 3497
  • [2] Tissue plasminogen activator, plasminogen activator inhibitor-1 and von Willebrand factor in the acute and convalescent phase of ischemic stroke
    Vlachova, I.
    Krcova, V.
    Herzig, R.
    Slavik, L.
    Bartkova, A.
    Vaverkova, H.
    Krupka, B.
    Sanak, D.
    Urbanek, K.
    Budikova, M.
    Sovova, E.
    Kanovsky, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 173 - 173
  • [3] Rosiglitazone alone or in combination with tissue plasminogen activator improves ischemic brain injury in an embolic model in rats
    Wang, Chen Xu
    Ding, Xiuqing
    Noor, Raza
    Pegg, Christina
    He, Chunyan
    Shuaib, Ashfaq
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2009, 29 (10): : 1683 - 1694
  • [4] Factors correlating with reperfusion injury after endovascular therapy and tissue plasminogen activator for acute ischemic stroke
    Soomro, Jazba
    Zelnick, Pamela
    Sarraj, Amrou
    NEUROLOGY, 2017, 88
  • [5] Collateral is brain: Low perfusion triggers spreading depolarization and futile reperfusion after acute ischemic stroke
    Torteli, Anna
    Toth, Reka
    Bari, Ferenc
    Farkas, Eszter
    Menyhart, Akos
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2024, 44 (10): : 1881 - 1887
  • [6] FATAL ISCHEMIC BRAIN EDEMA AFTER EARLY THROMBOLYSIS WITH TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE STROKE
    KOUDSTAAL, PJ
    STIBBE, J
    VERMEULEN, M
    BRITISH MEDICAL JOURNAL, 1988, 297 (6663): : 1571 - 1574
  • [7] Microglia depletion increase brain injury after acute ischemic stroke in aged mice
    Lee, Shirley Marino
    Hudobenko, Jacob
    McCullough, Louise D.
    Chauhan, Anjali
    EXPERIMENTAL NEUROLOGY, 2021, 336
  • [8] HUMAN AMNION EPITHELIAL CELLS DECREASE BRAIN INJURY AFTER TISSUE PLASMINOGEN ACTIVATOR THERAPY IN ISCHEMIC STROKE
    Arce, L. J. Barreto
    Kim, H. A.
    Zhang, S.
    Lim, R.
    Phan, T.
    Sobey, C. G.
    INTERNATIONAL JOURNAL OF STROKE, 2022, 17 (3_SUPPL) : 54 - 54
  • [9] PAI-1 but Not PAI-2 Gene Deficiency Attenuates Ischemic Brain Injury After Experimental Stroke
    Eva-Verena Griemert
    Kirsten Recarte Pelz
    Kristin Engelhard
    Michael K. Schäfer
    Serge C. Thal
    Translational Stroke Research, 2019, 10 : 372 - 380
  • [10] PAI-1 but Not PAI-2 Gene Deficiency Attenuates Ischemic Brain Injury After Experimental Stroke
    Griemert, Eva-Verena
    Pelz, Kirsten Recarte
    Engelhard, Kristin
    Schaefer, Michael K.
    Thal, Serge C.
    TRANSLATIONAL STROKE RESEARCH, 2019, 10 (04) : 372 - 380